WO1997009971A3 - High capacity, superabsorbent drug reservoirs for use in transdermal drug delivery systems - Google Patents

High capacity, superabsorbent drug reservoirs for use in transdermal drug delivery systems Download PDF

Info

Publication number
WO1997009971A3
WO1997009971A3 PCT/US1996/014784 US9614784W WO9709971A3 WO 1997009971 A3 WO1997009971 A3 WO 1997009971A3 US 9614784 W US9614784 W US 9614784W WO 9709971 A3 WO9709971 A3 WO 9709971A3
Authority
WO
WIPO (PCT)
Prior art keywords
reservoirs
drug
high capacity
delivery systems
superabsorbent
Prior art date
Application number
PCT/US1996/014784
Other languages
French (fr)
Other versions
WO1997009971A2 (en
Inventor
Tung-Fen Chen
Chia-Ming Chiang
Janan Jona
Priti Joshi
Asha Ramdas
Original Assignee
Tung-Fen Chen
Chia-Ming Chiang
Janan Jona
Priti Joshi
Asha Ramdas
Cygnus Therapeutic Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tung-Fen Chen, Chia-Ming Chiang, Janan Jona, Priti Joshi, Asha Ramdas, Cygnus Therapeutic Systems filed Critical Tung-Fen Chen
Priority to AU72388/96A priority Critical patent/AU7238896A/en
Publication of WO1997009971A2 publication Critical patent/WO1997009971A2/en
Publication of WO1997009971A3 publication Critical patent/WO1997009971A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches

Abstract

High capacity drug reservoirs are provided for incorporation into transdermal drug delivery systems. The drug reservoirs are comprised of a superabsorbent material, typically a cross-linked polymer, which is capable of absorbing an amount of drug formulation corresponding to at least 15 grams formulation per gram of material. Methods for making and using transdermal systems containing such reservoirs are provided as well.
PCT/US1996/014784 1995-09-14 1996-09-13 High capacity, superabsorbent drug reservoirs for use in transdermal drug delivery systems WO1997009971A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU72388/96A AU7238896A (en) 1995-09-14 1996-09-13 High capacity, superabsorbent drug reservoirs for use in transdermal drug delivery systems

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US52865595A 1995-09-14 1995-09-14
US08/528,655 1995-09-14
US58284395A 1995-12-29 1995-12-29
US08/582,843 1995-12-29
US08/713,071 1996-09-12

Publications (2)

Publication Number Publication Date
WO1997009971A2 WO1997009971A2 (en) 1997-03-20
WO1997009971A3 true WO1997009971A3 (en) 1997-04-24

Family

ID=27062784

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1996/014784 WO1997009971A2 (en) 1995-09-14 1996-09-13 High capacity, superabsorbent drug reservoirs for use in transdermal drug delivery systems

Country Status (2)

Country Link
AU (1) AU7238896A (en)
WO (1) WO1997009971A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9186335B2 (en) 2002-07-30 2015-11-17 Ucb Pharma Gmbh Hot melt TTS for administering rotigotine

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5906830A (en) * 1995-09-08 1999-05-25 Cygnus, Inc. Supersaturated transdermal drug delivery systems, and methods for manufacturing the same
US5902603A (en) * 1995-09-14 1999-05-11 Cygnus, Inc. Polyurethane hydrogel drug reservoirs for use in transdermal drug delivery systems, and associated methods of manufacture and use
US5891461A (en) * 1995-09-14 1999-04-06 Cygnus, Inc. Transdermal administration of olanzapine
US5807570A (en) * 1995-09-29 1998-09-15 Cygnus, Inc. Transdermal administration of ropinirole and analogs thereof
AU1429697A (en) * 1995-12-29 1997-07-28 Cygnus, Inc. Systems and methods for the transdermal administration of androgenic agents
DE19814084B4 (en) 1998-03-30 2005-12-22 Lts Lohmann Therapie-Systeme Ag D2 agonist-containing transdermal therapeutic system for the treatment of Parkinson's syndrome and process for its preparation
DE10128685A1 (en) * 2001-06-13 2002-12-19 Beiersdorf Ag Self-adhesive sticking plaster matrix material comprising active material and penetration enhancer, useful for skin care, especially controlled application of active material to skin
DE10220114A1 (en) * 2002-05-06 2003-11-20 Beiersdorf Ag Drug delivery system used for controlled release of essential oils comprises matrix plaster based on self adhesive, gas permeable polyurethane
DE10334188B4 (en) 2003-07-26 2007-07-05 Schwarz Pharma Ag Use of rotigotine to treat depression

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0297769A1 (en) * 1987-06-29 1989-01-04 E.R. Squibb & Sons, Inc. Process for preparing a wound dressing comprising a hydrophilic acrylic adhesive layer.
EP0399432A2 (en) * 1989-05-25 1990-11-28 Takeda Chemical Industries, Ltd. Transdermal therapeutic composition
EP0405993A2 (en) * 1989-06-28 1991-01-02 James River Corporation Of Virginia Superabsorbent wound dressing
US5248676A (en) * 1990-05-17 1993-09-28 Hisamitsu Pharmaceutical Co., Inc. Estradiol percutaneous administration preparations
US5328935A (en) * 1993-03-26 1994-07-12 The Procter & Gamble Company Method of makig a superabsorbent polymer foam

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0297769A1 (en) * 1987-06-29 1989-01-04 E.R. Squibb & Sons, Inc. Process for preparing a wound dressing comprising a hydrophilic acrylic adhesive layer.
EP0399432A2 (en) * 1989-05-25 1990-11-28 Takeda Chemical Industries, Ltd. Transdermal therapeutic composition
EP0405993A2 (en) * 1989-06-28 1991-01-02 James River Corporation Of Virginia Superabsorbent wound dressing
US5248676A (en) * 1990-05-17 1993-09-28 Hisamitsu Pharmaceutical Co., Inc. Estradiol percutaneous administration preparations
US5328935A (en) * 1993-03-26 1994-07-12 The Procter & Gamble Company Method of makig a superabsorbent polymer foam

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9186335B2 (en) 2002-07-30 2015-11-17 Ucb Pharma Gmbh Hot melt TTS for administering rotigotine

Also Published As

Publication number Publication date
WO1997009971A2 (en) 1997-03-20
AU7238896A (en) 1997-04-01

Similar Documents

Publication Publication Date Title
WO1999033853A3 (en) Carbohydrates, useful in solid delivery systems
CA2286001A1 (en) Implantation composition comprising glass particles
AU628647B2 (en) Osmotically enhanced absorbent structures
AU632539B2 (en) Pharmaceutical compositions useful as drug delivery vehicles and/or as wound dressings
CA2004598A1 (en) Medicinal aerosol formulations
CA2313642A1 (en) Pharmaceutical hydrogel formulations, drug delivery devices and methods
NZ336462A (en) Pharmaceutical composition of fenofibrate with high biological availability
WO1998027963A3 (en) Gel composition and methods
EP0392426A3 (en) Emulsifier-free hand and body lotion
AU4029593A (en) Polymer composition, absorbent material composition, their production and their use
EP0891768A3 (en) Scleroglucans and cosmetic compositions containing them
CA2187353A1 (en) Liquid delivery compositions
EP0402031A3 (en) Injectable polymeric bodies
AU4101693A (en) Subcutaneous implantable multiple agent delivery system
EP0528035A4 (en) Polyelectrolyte complex antibacterial agent and antibacterial material
ZA899780B (en) Cosmetic or pharmaceutical composition containing microspheres of polymers or of fatty substances filled with at least one active product
GR3030732T3 (en) Pharmaceutical compositions including a drug, a cross-linked polymeric substance, an oil, and a surface active agent.
CA2225162A1 (en) Oriented medical tubing
WO1997009971A3 (en) High capacity, superabsorbent drug reservoirs for use in transdermal drug delivery systems
CA2109956A1 (en) Nitroglycerine plaster and process for making it
IE870064L (en) Sustained release capsule
CA2265678A1 (en) Electrotransport drug delivery reservoirs containing inert fillers
AU1671799A (en) Medicament preparation in the form of a tablet or pellet for acid-labile active substances
SE8601563D0 (en) MATERIAL MATERIAL, PROCEDURES FOR PREPARING IT AND USING IT
IE831030L (en) Benzopyrans and benzothiopyrans

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: CA